Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help ...

Palantir's stock is up nearly 10 % month-to-date and has gone even higher year-to-date, as bullish sentiment surges ahead of its second quarter earnings. Tempus AI shares, currently at about $64, have ...

Add Yahoo as a preferred source to see more of our stories on Google. For decades, the pharmaceutical industry has defended sky-high drug prices by pointing to the high costs of research and ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

Big Pharma recently announced a marketing campaign posing as patient advocacy. The industry’s trade association and advocacy arm said it is spending hundreds of billions of dollars to develop drugs ...